Dr. Leland Shapiro is a leading infectious-diseases specialist and physician-scientist with more than two decades of research experience in cytokine biology, HIV molecular biology, and infectious-diseases pathogenesis. He has authored over 100 peer-reviewed publications, contributed to leading journals, and serves as an Associate Editor for Frontiers in Microbiology.

He was previously recognized for his discovery of alpha-1 antitrypsin as an endogenous inhibitor of HIV.

Currently, Dr. Shapiro’s research — supported by The Emily Foundation — challenges the widely accepted “cytokine storm” theory of infection-related illness. His landmark publication, “Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis,” has generated international attention and may lead to a new, biologically consistent model of how infections cause disease.

In addition, Dr. Shapiro has developed innovative diagnostic tools, such as the Ferritin-to-Procalcitonin Ratio for distinguishing viral from bacterial infections, and has collaborated on numerous clinical investigations.

His work reflects a bold, theory-driven approach to improving patient care and reshaping global understanding of infectious disease.

Appointment
Associate Professor of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine
Clinical role
Staff Physician, Infectious Diseases, Denver Veterans Affairs Medical Center
Editorial
Associate Editor, Frontiers in Microbiology
Published work
100+ peer-reviewed publications spanning cytokine biology, HIV molecular biology, sepsis, and infectious-disease pathogenesis

Research & Publications Latest News